Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2022
August 2022, Vol 12, No 8
August 2022, Vol 12, No 8
Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer
By
William King
ASCO 2022 Highlights
Targeting
HER2
with the antibody–drug conjugate fam-trastuzumab deruxtecan-nxki (Enhertu; T-DXd) provided clinically meaningful benefits for patients with
HER2
-low metastatic breast cancer, according to findings presented at the 2022 American Society of Clinical Oncology Annual Meeting.
Read More ›
Getting Real with the New Enhancing Oncology Model
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
We now know what will follow the Oncology Care Model (OCM). On June 27, 2022, the Centers for Medicare & Medicaid Services’ (CMS) Innovation Center announced the voluntary Enhancing Oncology Model (EOM).
Read More ›
The Patient Experience: How to Plan for Success
By
Jason Lockard, CMOM-HEM/ONC
;
Bettinna Signori, CMOM-HEM/ONC
Practice Management
There are several methods that can be used to gain a better perspective when determining the success of an oncology practice and its operations. Financial evaluation, access to care, quality metrics, and employee engagement are just a few of the operational elements that are important to consider, especially as they relate to the overall patient experience.
Read More ›
Lisocabtagene Maraleucel Yields High Response Rates in Patients with Relapsed or Refractory LBCL Who Are Not Candidates for Transplant
By
William King
ASCO 2022 Highlights
More than 50% of adults with refractory or relapsed large B-cell lymphoma (LBCL) who were not deemed candidates for high-dose chemotherapy and hematopoietic stem-cell transplantation (HSCT) had complete responses (CRs) following treatment with lisocabtagene maraleucel (Breyanzi).
Read More ›
Black Patients with Cancer and COVID-19 More Likely to Have Treatment Disruptions Than White Patients
By
Patricia Stewart
ASCO 2022 Highlights
In the United States, black or African-American patients with cancer and COVID-19 were more likely than non-Hispanic white patients to have delays or disruptions in cancer treatment during the pandemic, according to results of the American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry that were presented during the 2022 ASCO meeting.
Read More ›
Digital Therapeutics Is the Key to New Patient Management Demands for Physicians
By
Cindy Borassi
;
Bob Gold, MS
;
Dawn Holcombe, MBA, FACMPE, ACHE
Healthcare Technology
The new proposed Centers for Medicare & Medicaid Services (CMS) Enhancing Oncology Model sets forth the expectation that medical practices will actively engage with patients as they go about their daily lives between office visits, tracking symptoms, and monitoring adverse events that can lead to costly medical interventions.
Read More ›
Select Ongoing Trials Currently Enrolling Patients with Head and Neck Cancer
Clinical Trials Tracker
The following clinical trials represent a selection of key studies currently recruiting patients with head and neck cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials.
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
3.
2023 Spotlight: Amgen
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes